NeoGenomics
@NeoGenomics
Followers
2K
Following
2K
Media
3K
Statuses
4K
One Lab. Vital Answers.
Fort Myers, FL
Joined January 2010
NeoGenomics gives you needed insights to develop, refine & commercialize therapies that can change patient lives. 💡Smarter development.🚀 Faster market entry.📊 More confident decisions.Let’s talk about how we can support your next oncology breakthrough:
1
0
2
#NeoGenomics colleagues have been in San Antonio, Texas, for the HealthTrust University Conference. We appreciated the opportunity to share with HealthTrust members how our comprehensive solutions make us a trusted partner.
0
0
0
It has been great connecting with everyone at the HealthTrust University Conference in San Antonio! Thank you to everyone who has stopped by booth #836 to meet the #NeoGenomics team and explore how our solutions can support HealthTrust members.
0
0
1
We’re excited to connect at the HealthTrust University Conference! Discover the full breadth of our solutions and see how #NeoGenomics can be a valuable partner for HealthTrust members.
0
0
2
Claudin18.2 may have been on your radar for years – and now, it’s an actionable target. We are proud to be one of the leading labs offering Claudin18.2 testing. Ready to put Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma into practice? Learn more:
0
1
2
3: Shitara K, Lordick F, Bang YJ, et al. Lancet 2023 Apr 14:S0140-6736(23)00620-7. Xu RH, Shitara K, Ajani JA, et al. #405736. Presented at: March American Society of Clinical Oncology Plenary Series; March 22, 2023.
0
0
0
References:.1: Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to biological systems. Trends Biochem Sci 2019;44(2):141-52. 2: Hu YJ, Wang YD, Tan FQ, Yang WX. Regulation of paracellular permeability: factors and mechanisms. Mol Biol Rep 2013;40:6123-42.
1
0
1
IHC testing for CLDN18.2 is an important tool when creating treatment plans for gastric/GEJ patients. Learn more:
2
0
2
Lung cancer demands precision. Comprehensive #GenomicProfiling can reveal actionable insights and targeted therapy options. Explore our comprehensive tissue and #LiquidBiopsy solutions:
1
0
2
PanTracer LBx provides minimally invasive, guideline-driven testing for over 500 genes, with results delivered within 7 days to enable real-time decision-making. Improving patient care is only a click away:
1
0
3
The HealthTrust University Conference is August 18-20 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. Find #NeoGenomics at booth #836!
0
0
1
NeoGenomics is attending the 2025 Oncology Clinical Updates conference in Napa Valley, CA, August 2–3. Stop by our table at the Hyatt Regency Sonoma Wine Country—we’d love to connect!.🔗
1
0
0
Sarcoma is rare—and accurate testing is critical. #NeoGenomics offers advanced testing solutions to help guide care for soft tissue and bone sarcomas. Explore our Sarcoma Comprehensive NGS Fusion Panel:.
0
0
3
#NeoGenomics is a sponsor of ASCO Direct™ Denver! Make plans to visit us and learn about our #oncology solutions for solid tumors, hematological cancers, and more. We’ll see you July 26 and 27 in Denver, #Colorado.
0
0
0
Thank you to everyone who visited us during #Breakthroughs25! We enjoyed the great conversations and look forward to continuing the momentum.
0
0
2
#Breakthroughs25 is underway in National Harbor, MD. Visit #NeoGenomics at booth #1617 to see how we're helping #oncologists drive smarter, more personalized solutions.
0
1
2
#Breakthroughs25 kicks off today! Visit us at our booth to see how we're helping #oncologists drive smarter, more personalized solutions.
0
0
3
#NeoGenomics is a sponsor of ASCO Direct™ Denver! Make plans to visit us and learn about our #oncology solutions for solid tumors, hematological cancers, and more. We’ll see you July 26 and 27 in Denver, #Colorado.
0
1
4
Two samples, one story: Meet PanTracerâ„¢, the future of CGP in oncology.
0
0
1
PanTracerâ„¢ Tissue and Liquid Biopsy are available for #pharma partners to provide pan-tumor, comprehensive genomic profiling across both tissue and liquid biopsy. Learn more:
0
0
2